venetoclax (venclexta) Report issue

Small molecule Orphan Drug FDA Approved FDA First in Class Accelerated Approval FDA Priority Review FDA
AACT ChEMBL DrugBank Drug Central Drugs@FDA KEGG MeSH PubChem repoDB
Back

Drug Pricing Summary

AUS PBS

$5.2959 - $49.6009

VA Big4

$7.2500 - $72.9900

VA FSS

$9.3350 - $93.3978

Drug Product Pricing

Product $/unit Ctry. List Type
Product (units) Manufacturer
venetoclax 100 mg (TABLET) $49.6009 AUS PBS generic
  • Venclexta (120)
    		•  AbbVie Pty Ltd
    venetoclax 100 mg (TABLET) $71.7484 VA Big4
  • Venclexta (180)
    		•  Abbvie US LLC
    venetoclax 100 mg (TABLET) $72.4108 VA Big4
  • Venclexta (120)
    		•  Abbvie US LLC
    venetoclax 100 mg (TABLET) $72.9900 VA Big4
  • Venclexta (1)
    		•  Abbvie US LLC
    venetoclax 100 mg (TABLET) $93.3900 VA FSS
  • Venclexta (1)
    		•  Abbvie US LLC
    venetoclax 100 mg (TABLET) $93.3977 VA FSS
  • Venclexta (120)
    		•  Abbvie US LLC
    venetoclax 100 mg (TABLET) $93.3978 VA FSS
  • Venclexta (180)
    		•  Abbvie US LLC
    venetoclax 10 mg (TABLET) $5.2959 AUS PBS generic
  • Venclexta (14)
    		•  AbbVie Pty Ltd
    venetoclax 10 mg (TABLET) $7.2500 VA Big4
  • Venclexta (2)
    		•  Abbvie US LLC
    venetoclax 10 mg (TABLET) $7.2686 VA Big4
  • Venclexta (14)
    		•  Abbvie US LLC
    venetoclax 10 mg (TABLET) $9.3350 VA FSS
  • Venclexta (2)
    		•  Abbvie US LLC
    venetoclax 10 mg (TABLET) $9.3400 VA FSS
  • Venclexta (14)
    		•  Abbvie US LLC
    venetoclax 50 mg (TABLET) $26.4776 AUS PBS generic
  • Venclexta (7)
    		•  AbbVie Pty Ltd
    venetoclax 50 mg (TABLET) $36.3114 VA Big4
  • Venclexta (7)
    		•  Abbvie US LLC
    venetoclax 50 mg (TABLET) $36.4100 VA Big4
  • Venclexta (1)
    		•  Abbvie US LLC
    venetoclax 50 mg (TABLET) $46.6986 VA FSS
  • Venclexta (7)
    		•  Abbvie US LLC
    venetoclax 50 mg (TABLET) $46.7000 VA FSS
  • Venclexta (1)
    		•  Abbvie US LLC

    Note: This drug pricing data is preliminary, incomplete, and may contain errors.

    Feedback

    Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

    Report issue